SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom's strong Q1 earnings, significantly raised guidance for AI revenue, and new partnerships with major AI players like OpenAI are fueling conversation. While many celebrate these "grand slam" results and long-term projections, a notable community discussion centers on the stock's initial muted after-hours reaction and whether it will sustain gains or follow the pattern of other big tech post-earnings sell-offs.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull ($BULL) is trending following its latest earnings report, which showcased robust revenue and user growth but drew mixed community reactions regarding its diluted profitability figures and ongoing stock dilution. Bulls emphasize the platform's expanding market share and customer assets, while bears voice frustration over management's perceived inaction in translating operational success into shareholder value.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is trending after reporting lower-than-expected revenue in its Q4 earnings, fueling a polarized community discussion. While bears label the stock a "quantum scam" given its high valuation against minimal sales, bulls point to a robust cash position, the achievement of 99.9% gate fidelity, and recent system orders as strong indicators of its long-term potential in the nascent quantum technology sector.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences (SLS) is drawing significant attention amidst fervent anticipation for imminent Phase 3 REGAL trial results for its AML drug, GPS. The community is debating a potential groundbreaking 'near-cure' and an impending multi-billion dollar buyout, with bulls pointing to strong patient survival signals and corporate silence, while skeptics warn of an overhyped biotech play.

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Verastem Inc

Verastem is actively discussed following its strategic decision to discontinue the RAMP 203 trial, prioritizing the VS-7375 KRAS G12D inhibitor and its robust 69% response rate, alongside a solid preliminary Q4 revenue report. While some investors see this pipeline focus and increasing institutional interest as a long-term positive, many express frustration over the stock's persistent decline and its underperformance relative to other trending RAS-targeting biotechs.

Veeva Systems, Inc. engages in the provision of industry cloud solutions for the global life sciences industry. Its solutions enable pharmaceutical and other life sciences companies to realize the benefits of modern cloud-based architectures and mobile applications for their most critical business functions, without compromising industry-specific functionality or regulatory compliance. The firm's customer relationship management solutions enable its customers to increase the productivity and compliance of their sales and marketing functions. Its regulated content management and collaboration solutions enable its customers to more efficiently manage regulated, content-centric processes across the enterprise. The company's customer master solution enables customers to more effectively manage complex healthcare provider and healthcare organization data. The company was founded by Mark Armenante, Peter P. Gassner, Doug Ostler, Mitch Wallace and Matthew J. Wallach on January 12, 2007, and is headquartered in Pleasanton, CA.

Veeva Systems Inc - Ordinary Shares - Class A

Veeva Systems is trending after reporting strong financial results and optimistic guidance, fueling community discussion around its AI advancements and the prospect of a stock split to broaden investor access. The market is largely optimistic about its continued growth in the mission-critical life sciences sector.

Okta, Inc. engages in the provision of an identity management platform for enterprises. It operates through the United States and International geographical segments. The firm's products include single sign-on, multi-factor authentication, access gateway, API access management, authentication, adaptive MFA and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA.

Okta Inc - Ordinary Shares - Class A

Okta Inc

Okta is trending as it delivered stronger-than-expected Q4 results but projected softer Q1 guidance, including its first-ever single-digit revenue growth since IPO, sparking community debate over the company's trajectory amidst broader economic caution impacting enterprise tech spending.

Amprius Technologies, Inc. engages in the development, manufacture, and market lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the United States and Rest of the World geographical segments. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius Technologies is trending following its robust earnings report, which highlighted significant revenue and adjusted EPS beats, positive full-year guidance, and a strategic U.S. manufacturing partnership for its high-performance silicon batteries. The community is actively discussing the company's progress towards profitability and its strengthened position for defense contracts and NDAA compliance within the rapidly expanding drone and eVTOL markets, despite a notable one-time charge affecting net results.

BlackRock Institutional Trust Company N.A. - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending as investors weigh its appeal as a safe-haven asset amidst escalating Middle East tensions, while simultaneously navigating the uncertainty of persistent inflation signals and shifting expectations for Federal Reserve policy.

Stem, Inc. engages in the provision of an energy storage system, hardware, ongoing software platform and professional services, and solar asset performance monitoring and control. The company was founded in 2009 and is headquartered in Houston, TX.

Stem Inc - Ordinary Shares - Class A

Stem Inc

Stem Inc. is trending following its earnings report, which presented the company's first positive adjusted EBITDA, a point of optimism for those noting cost cuts and a software pivot. However, community discussions are divided, with many highlighting flat guidance for 2026, continued underlying losses, and significant debt as major concerns for the energy storage software firm.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Provectus Biopharmaceuticals, Inc. is a development stage biopharmaceutical company, which engages in the development of ethical pharmaceuticals for oncology and dermatology indications. Its prescription drugs treat several life-threatening cancers including metastatic melanoma, liver cancer, and breast cancer. The company was founded by Eric A. Wachter on January 17, 2002 and is headquartered in Knoxville, TN.

PVCT
Provectus Biopharmaceuticals Inc.

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest PVCT News

PVCTProvectus Biopharmaceuticals Inc.